Cargando…

Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections

Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in U.S. cystic fibrosis (CF) patients and is associated with worse clinical outcomes in CF. These infections often become chronic despite repeated antibiotic therapy. Here, we assessed whether bacterial phenotypes, including anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Kuan-Yi, Wagner, Nikki J., Velez, Amanda Z., Ceppe, Agathe, Conlon, Brian P., Muhlebach, Marianne S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927320/
https://www.ncbi.nlm.nih.gov/pubmed/36519944
http://dx.doi.org/10.1128/spectrum.04061-22
_version_ 1784888457322037248
author Lu, Kuan-Yi
Wagner, Nikki J.
Velez, Amanda Z.
Ceppe, Agathe
Conlon, Brian P.
Muhlebach, Marianne S.
author_facet Lu, Kuan-Yi
Wagner, Nikki J.
Velez, Amanda Z.
Ceppe, Agathe
Conlon, Brian P.
Muhlebach, Marianne S.
author_sort Lu, Kuan-Yi
collection PubMed
description Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in U.S. cystic fibrosis (CF) patients and is associated with worse clinical outcomes in CF. These infections often become chronic despite repeated antibiotic therapy. Here, we assessed whether bacterial phenotypes, including antibiotic tolerance, can predict the clinical outcomes of MRSA infections. MRSA isolates (n = 90) collected at the incident (i.e., acute) and early infection states from 57 patients were characterized for growth rates, biofilm formation, hemolysis, pigmentation, and vancomycin tolerance. The resistance profiles were consistent with those in prior studies. Isolates from the early stage of infection were found to produce biofilms, and 70% of the isolates exhibited delta-hemolysis, an indicator of agr activity. Strong vancomycin tolerance was present in 24% of the isolates but was not associated with intermediate vancomycin susceptibility. There were no associations between these phenotypic measures, antibiotic tolerance, and MRSA clearance. Our research suggests that additional factors may be relevant for predicting the clearance of MRSA. IMPORTANCE Chronic MRSA infections remain challenging to treat in patients with cystic fibrosis (CF). The ability of the bacterial population to survive high concentrations of bactericidal antibiotics, including vancomycin, despite lacking resistance is considered one of the main reasons for treatment failures. The connection between antibiotic tolerance and treatment outcomes remains unexplored and can be crucial for prognosis and regimen design toward eradication. In this study, we measured the capacity of 90 MRSA isolates from CF patients to form vancomycin-tolerant persister cells and evaluated their correlation with the clinical outcomes. Additionally, various traits that could reflect the metabolism and/or virulence of those MRSA isolates were systematically phenotyped and included for their predictive power. Our research highlights that despite the importance of antibiotic tolerance, additional factors need to be considered for predicting the clearance of MRSA.
format Online
Article
Text
id pubmed-9927320
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-99273202023-02-15 Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections Lu, Kuan-Yi Wagner, Nikki J. Velez, Amanda Z. Ceppe, Agathe Conlon, Brian P. Muhlebach, Marianne S. Microbiol Spectr Research Article Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in U.S. cystic fibrosis (CF) patients and is associated with worse clinical outcomes in CF. These infections often become chronic despite repeated antibiotic therapy. Here, we assessed whether bacterial phenotypes, including antibiotic tolerance, can predict the clinical outcomes of MRSA infections. MRSA isolates (n = 90) collected at the incident (i.e., acute) and early infection states from 57 patients were characterized for growth rates, biofilm formation, hemolysis, pigmentation, and vancomycin tolerance. The resistance profiles were consistent with those in prior studies. Isolates from the early stage of infection were found to produce biofilms, and 70% of the isolates exhibited delta-hemolysis, an indicator of agr activity. Strong vancomycin tolerance was present in 24% of the isolates but was not associated with intermediate vancomycin susceptibility. There were no associations between these phenotypic measures, antibiotic tolerance, and MRSA clearance. Our research suggests that additional factors may be relevant for predicting the clearance of MRSA. IMPORTANCE Chronic MRSA infections remain challenging to treat in patients with cystic fibrosis (CF). The ability of the bacterial population to survive high concentrations of bactericidal antibiotics, including vancomycin, despite lacking resistance is considered one of the main reasons for treatment failures. The connection between antibiotic tolerance and treatment outcomes remains unexplored and can be crucial for prognosis and regimen design toward eradication. In this study, we measured the capacity of 90 MRSA isolates from CF patients to form vancomycin-tolerant persister cells and evaluated their correlation with the clinical outcomes. Additionally, various traits that could reflect the metabolism and/or virulence of those MRSA isolates were systematically phenotyped and included for their predictive power. Our research highlights that despite the importance of antibiotic tolerance, additional factors need to be considered for predicting the clearance of MRSA. American Society for Microbiology 2022-12-15 /pmc/articles/PMC9927320/ /pubmed/36519944 http://dx.doi.org/10.1128/spectrum.04061-22 Text en Copyright © 2022 Lu et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Lu, Kuan-Yi
Wagner, Nikki J.
Velez, Amanda Z.
Ceppe, Agathe
Conlon, Brian P.
Muhlebach, Marianne S.
Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections
title Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections
title_full Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections
title_fullStr Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections
title_full_unstemmed Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections
title_short Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections
title_sort antibiotic tolerance and treatment outcomes in cystic fibrosis methicillin-resistant staphylococcus aureus infections
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927320/
https://www.ncbi.nlm.nih.gov/pubmed/36519944
http://dx.doi.org/10.1128/spectrum.04061-22
work_keys_str_mv AT lukuanyi antibiotictoleranceandtreatmentoutcomesincysticfibrosismethicillinresistantstaphylococcusaureusinfections
AT wagnernikkij antibiotictoleranceandtreatmentoutcomesincysticfibrosismethicillinresistantstaphylococcusaureusinfections
AT velezamandaz antibiotictoleranceandtreatmentoutcomesincysticfibrosismethicillinresistantstaphylococcusaureusinfections
AT ceppeagathe antibiotictoleranceandtreatmentoutcomesincysticfibrosismethicillinresistantstaphylococcusaureusinfections
AT conlonbrianp antibiotictoleranceandtreatmentoutcomesincysticfibrosismethicillinresistantstaphylococcusaureusinfections
AT muhlebachmariannes antibiotictoleranceandtreatmentoutcomesincysticfibrosismethicillinresistantstaphylococcusaureusinfections